UPDF AI

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

M. Leske,A. Heijl,4 Authors,Paul P. Lee

2003 · DOI: 10.1097/00132578-200310000-00007
A M A Archives of Ophthalmology · 2,137 Citations

TLDR

Patients treated in the EMGT had half of the progression risk of control patients, including the effect of EMGT treatment, and the magnitude of initial IOP reduction was a major factor influencing outcome.